T1	Participants 109 153	patients with non-valvar atrial fibrillation
T2	Participants 489 570	patients taking part in the SPAF (stroke prevention in atrial fibrillation) study
T3	Participants 682 721	1321 participants in the SPAF III study
T4	Participants 823 866	1321 patients with atrial fibrillation (AF)
